Posts

Showing posts with the label Dermatomyositis

Dermatomyositis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Dermatomyositis (DM) is an idiopathic inflammatory myopathy multisystem disorder characterized by progressive, symmetrical proximal muscle weakness and pathognomonic or characteristic cutaneous manifestations. In some patients with DM, cutaneous disease exists in the absence of objective evidence of muscle inflammation, and these cases are referred to as amyopathic DM. The myopathy primarily affects the proximal muscles, is usually symmetrical, and is slowly progressive over weeks to months. Initial complaints include myalgias, fatigue, or weakness manifested as an inability to climb stairs, raise the arms for actions like hair grooming or shaving, rise from a squatting or sitting position, or a combination of these features. Arthralgias and arthritis may be present in up to one-fourth of patients with inflammatory myopathy. As manifested by dysphagia, the esophagal disease is estimated to be present in 15% to 50% of patients with inflammatory myopathy. The pulmonary disease occur...